Anagenics Limited (ASX: $AN1) has announced significant organisational changes, effective 8 March 2024. Karen Matthews will assume the role of CEO, focusing on driving profitability through cost base reductions and strategic growth. Scott Greasley will return to his role as Executive Director to drive profitable growth via M&A and corporate strategy. The company aims to achieve a breakeven position with a projected annualised cost base reduction of approximately $1,500,000.
The organisational changes at Anagenics are aimed at accelerating cost base reduction and driving profitability. Karen Matthews, with her extensive experience in the beauty industry, will lead the company in achieving month-to-month profitability and positive cash flow. Scott Greasley will focus on driving profitable growth through M&A and corporate strategy. These changes align with our commitment to transforming the business and achieving a breakeven position. We are dedicated to the continued success and growth of Anagenics.
Anagenics Limited (ASX: $AN1) has announced the appointment of Karen Matthews as CEO, effective 8 March 2024, to drive profitability through cost base reductions and strategic growth. The company aims to achieve month-to-month profitability and positive cash flow, with a projected annualised cost base reduction of approximately $1,500,000. Scott Greasley will focus on driving profitable growth through M&A and corporate strategy, supported by major shareholder Hancock & Gore. The Board remains committed to the transformation of the business and the continued success of Anagenics.